Geneos Wealth Management’s Greenwich LifeSciences GLSI Stock Holding History

Geneos Wealth Management’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.06K	Hold	88	–	–	﹤0.01%	2319
2026 Q1	$2.11K	Hold	88	–	–	﹤0.01%	2311
2025 Q4	$1.85K	Hold	88	–	–	﹤0.01%	2327
2025 Q3	$876	Hold	88	–	–	﹤0.01%	2417
2025 Q2	$798	Hold	88	–	–	﹤0.01%	3042
2025 Q1	$840	Hold	88	–	–	﹤0.01%	2972
2024 Q4	$988	Hold	88	–	–	﹤0.01%	2771
2024 Q3	$1.26K	Hold	88	–	–	﹤0.01%	2393
2024 Q2	$1.52K	Hold	88	–	–	﹤0.01%	1929
2024 Q1	$1.75K	Hold	88	–	–	﹤0.01%	1921
2023 Q4	$926	Hold	88	–	–	﹤0.01%	2023
2023 Q3	$778	Hold	88	–	–	﹤0.01%	2057
2023 Q2	$849	Buy	+88	New	+$984	﹤0.01%	2034

Other funds holding GLSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geneos Wealth Management's GLSI Position: Q2 2026 in Review

Geneos Wealth Management held its Greenwich LifeSciences (GLSI) position steady in Q2 2026 at 88 shares worth $2.06K. The position accounts for ﹤0.01% of the portfolio, ranked #2319.

Geneos Wealth Management first reported a position in GLSI in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.11K in Q1 2026. 57 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

Geneos Wealth Management held 88 shares of Greenwich LifeSciences worth $2.06K as of Q2 2026.
Geneos Wealth Management left its Greenwich LifeSciences share count unchanged in Q2 2026.
Greenwich LifeSciences made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2319 holding.
Geneos Wealth Management first reported a position in Greenwich LifeSciences in Q2 2023 and has held it in 13 quarters since.
Geneos Wealth Management's Greenwich LifeSciences position peaked at $2.11K in Q1 2026.
57 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.